View in EDS

A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity.

Saved in:
Bibliographic Details
Title: A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity.
Authors: Olwill SA; Corresponding Authors: Shane A. Olwill, Pieris AG, Lise-Meitner-Strasse 30, 85354 Freising, Germany. olwill@pieris-ag.com., Joffroy C, Gille H, Vigna E, Matschiner G, Allersdorfer A, Lunde BM, Jaworski J, Burrows JF, Chiriaco C, Christian HJ, Hülsmeyer M, Trentmann S, Jensen K, Hohlbaum AM, Audoly L
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2013 Nov; Vol. 12 (11), pp. 2459-71. Date of Electronic Publication: 2013 Sep 03.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24002935
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Olwill+SA%22">Olwill SA</searchLink>; Corresponding Authors: Shane A. Olwill, Pieris AG, Lise-Meitner-Strasse 30, 85354 Freising, Germany. olwill@pieris-ag.com.<br /><searchLink fieldCode="AU" term="%22Joffroy+C%22">Joffroy C</searchLink><br /><searchLink fieldCode="AU" term="%22Gille+H%22">Gille H</searchLink><br /><searchLink fieldCode="AU" term="%22Vigna+E%22">Vigna E</searchLink><br /><searchLink fieldCode="AU" term="%22Matschiner+G%22">Matschiner G</searchLink><br /><searchLink fieldCode="AU" term="%22Allersdorfer+A%22">Allersdorfer A</searchLink><br /><searchLink fieldCode="AU" term="%22Lunde+BM%22">Lunde BM</searchLink><br /><searchLink fieldCode="AU" term="%22Jaworski+J%22">Jaworski J</searchLink><br /><searchLink fieldCode="AU" term="%22Burrows+JF%22">Burrows JF</searchLink><br /><searchLink fieldCode="AU" term="%22Chiriaco+C%22">Chiriaco C</searchLink><br /><searchLink fieldCode="AU" term="%22Christian+HJ%22">Christian HJ</searchLink><br /><searchLink fieldCode="AU" term="%22Hülsmeyer+M%22">Hülsmeyer M</searchLink><br /><searchLink fieldCode="AU" term="%22Trentmann+S%22">Trentmann S</searchLink><br /><searchLink fieldCode="AU" term="%22Jensen+K%22">Jensen K</searchLink><br /><searchLink fieldCode="AU" term="%22Hohlbaum+AM%22">Hohlbaum AM</searchLink><br /><searchLink fieldCode="AU" term="%22Audoly+L%22">Audoly L</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2013 Nov; Vol. 12 (11), pp. 2459-71. <i>Date of Electronic Publication: </i>2013 Sep 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24002935
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-13-0318
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2459
    Titles:
      – TitleFull: A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Olwill SA
      – PersonEntity:
          Name:
            NameFull: Joffroy C
      – PersonEntity:
          Name:
            NameFull: Gille H
      – PersonEntity:
          Name:
            NameFull: Vigna E
      – PersonEntity:
          Name:
            NameFull: Matschiner G
      – PersonEntity:
          Name:
            NameFull: Allersdorfer A
      – PersonEntity:
          Name:
            NameFull: Lunde BM
      – PersonEntity:
          Name:
            NameFull: Jaworski J
      – PersonEntity:
          Name:
            NameFull: Burrows JF
      – PersonEntity:
          Name:
            NameFull: Chiriaco C
      – PersonEntity:
          Name:
            NameFull: Christian HJ
      – PersonEntity:
          Name:
            NameFull: Hülsmeyer M
      – PersonEntity:
          Name:
            NameFull: Trentmann S
      – PersonEntity:
          Name:
            NameFull: Jensen K
      – PersonEntity:
          Name:
            NameFull: Hohlbaum AM
      – PersonEntity:
          Name:
            NameFull: Audoly L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2013 Nov
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1